Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

GNPS - HNRC samples co-analyzed with drug microbial incubation (MSV000095331)

ABSTRACT: HNRC samples co-analyzed with drug microbial incubation (MSV000095331) for retention time matching with drug microbial metabolites

INSTRUMENT(S): Q Exactive

ORGANISM(S): Homo Sapiens (ncbitaxon:9606)

SUBMITTER: Pieter C. Dorrestein

PROVIDER: MSV000096012 | GNPS | Wed Oct 02 20:52:00 BST 2024

REPOSITORIES: GNPS

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

20240814 HNRC drug microbial culture co-migration

Project description:Co-migration / spiking experiment to confirm the retention time of drug analogs detected in HNRC fecal samples with those in microbial cultures

2024-08-14 | MSV000095606 | MassIVE

20240930 HNRC sample HIV drug co-migration

Project description:Retention time check by co-migration of HIV drug standards with fecal samples from the HNRC cohort.

| MSV000095996 | MassIVE

GNPS - HNRC sample co-migration with drug microbial incubations

Project description:HNRC sample spiked by drug microbial incubations to check retention time match of drug microbial metabolites

2024-10-02 | MSV000096013 | GNPS

GNPS - 20240814 HNRC drug microbial culture co-migration

Project description:Co-migration / spiking experiment to confirm the retention time of drug analogs detected in HNRC fecal samples with those in microbial cultures

2024-08-14 | MSV000095606 | GNPS

GNPS - 20240930 HNRC sample HIV drug co-migration

Project description:Retention time check by co-migration of HIV drug standards with fecal samples from the HNRC cohort.

| MSV000095996 | GNPS

GNPS - Drug metabolites 5-ASA RT matching

Project description:Drug metabolites of 5-ASA, Retention time matching

2025-01-13 | MSV000096845 | GNPS

Predicting and manipulating drug inactivation by the human gut microbiome

Project description:The trillions of microorganisms in the human gastrointestinal tract are an underexplored aspect of pharmacology. Despite numerous examples of microbial effects on drug efficacy and toxicity, there is often an incomplete understanding of the underlying mechanisms. Here, we dissect the inactivation of the commonly prescribed cardiac glycoside, digoxin, by Eggerthella lenta. Whole genome transcriptional profiling, comparative genomics, and culture-based assays revealed a cytochrome-encoding operon up-regulated by digoxin, absent in non-metabolizing E. lenta strains, and predictive of the efficiency of digoxin inactivation by the human gut microbiome. Digoxin inactivation was further enhanced by microbial interactions and inhibited by arginine. Pharmacokinetic studies using gnotobiotic mice revealed that increasing dietary protein reduces the in vivo metabolism of digoxin by E. lenta, with significant changes to drug concentration in the urine and serum. These results emphasize the importance of viewing pharmacology from the perspective of both our human and microbial genomes. RNA-Seq analysis of Eggerthella lenta cultured with or without digoxin.

2013-06-15 | E-GEOD-43919 | biostudies-arrayexpress

Project description:HNRC- Plasma microbiome

| PRJEB36408 | ENA

Predicting and manipulating drug inactivation by the human gut microbiome

2013-06-15 | GSE43919 | GEO

Single-cell phenotyping and RNA sequencing reveal novel patterns of gene expression heterogeneity and regulation during growth and stress adaptation in a unicellular eukaryote

Project description:Phenotypic cell-to-cell variability is central for microbial populations and contributes to cell function, stress adaptation and drug resistance. Gene-expression heterogeneity underpins this variability, but has been challenging to study genome-wide. Here, we report a novel approach which combines imaging of individual fission yeast cells with single-cell RNA sequencing (scRNA-seq) and Bayesian normalisation. We analyse >2000 single cells and >700 matching RNA controls in various environmental conditions that include reposnse to various stresses as well as growth and entry into stationary phase.

2018-11-14 | E-MTAB-6825 | biostudies-arrayexpress

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data